Medicines360
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.medicines360.org
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Medicines360
- Target Recruit Count
- 105
- Registration Number
- NCT03642210
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
🇺🇸MomDoc Women's Health Research, Scottsdale, Arizona, United States
🇺🇸OB/GYN Research, University of California, Davis Health, Sacramento, California, United States
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
- First Posted Date
- 2009-10-15
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Medicines360
- Target Recruit Count
- 1910
- Registration Number
- NCT00995150
- Locations
- 🇺🇸
Magee Women's Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania, United States
© Copyright 2024. All Rights Reserved by MedPath